+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future



Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future



International Journal of Pharmaceutical Compounding 21(4): 293-298



3D printing is a standard tool in the automotive, aerospace, and consumer goods in industry and is gaining traction in pharmaceutical manufacturing, which has introduced a new element into dosage form development. This article, which represents part 3 of a 3-part article on the topic of 3D printing, discusses the compounding, formulation considerations, and the future of 3D printing.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 059436081

Download citation: RISBibTeXText

PMID: 28719372


Related references

Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1. International Journal of Pharmaceutical Compounding 21(2): 127-130, 2017

Basics of Compounding: 3D Printing--Pharmacy Applications, Part 2. International Journal of Pharmaceutical Compounding 21(3): 215-220, 2017

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 18: verification of automated compounding devices for parenteral nutrition compounding and finished preparation release checks and tests. International Journal of Pharmaceutical Compounding 14(2): 142-149, 2010

Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing. International Journal of Pharmaceutical Compounding 21(5): 388-392, 2018

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 4: considerations in selection and use of disinfectants and antiseptics. International Journal of Pharmaceutical Compounding 11(6): 492-499, 2007

The basics of compounding: compounding suppositores: part one-theoretical considerations. International Journal of Pharmaceutical Compounding 4(4): 289-293, 2000

Basics of compounding: the responsibilities of compounding personnel in implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 2. International Journal of Pharmaceutical Compounding 11(4): 313-323, 2007

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 12. International Journal of Pharmaceutical Compounding 13(2): 146-150, 2009

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 11. International Journal of Pharmaceutical Compounding 13(1): 56-62, 2009

Basics of compounding; considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 13. International Journal of Pharmaceutical Compounding 13(3): 234-238, 2009

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 8: stability and beyond-use dating. International Journal of Pharmaceutical Compounding 12(4): 344-353, 2008

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 16: suggested standard operating procedures. International Journal of Pharmaceutical Compounding 13(6): 546-553, 2009

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 15: personnel training, cleansing, and garbing. International Journal of Pharmaceutical Compounding 11(5): 420-426, 2009

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 14: environmental quality and control (continued). International Journal of Pharmaceutical Compounding 13(4): 322-329, 2009

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 7: microbial contamination risk levels, 12-hour use, and immediate use. International Journal of Pharmaceutical Compounding 12(3): 252-257, 2008